BSE filing, NSE: ANTHEM. Summary written from the filing by ALFA Finder's alert engine.
Anthem Biosciences Ltd: key numbers
- Share price
- ₹832.15
- Market cap
- ₹46,866 Cr
- Revenue (annual)
- ₹2,124 Cr
- Net profit (annual)
- ₹591.8 Cr
- P/E (TTM)
- 81.4×Sector 46.1×
- Promoter holding
- 71.40%-0.02% QoQ
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anthem Biosciences Ltd
All →Anthem Biosciences Board Meeting Date
Anthem Biosciences scheduled a Board meeting for November 3, 2026 to approve Q1 and H1 FY27 financial results. The trading window remains closed until November 5, 2026.
Anthem Biosciences Other Announcement
Designated Person Viridity Tone LLP sold shares of Anthem Biosciences Ltd worth ₹82.67 Crore via market sale.
- Value
- ₹82.67 Cr
Anthem Biosciences Legal & Regulatory
Anthem Biosciences Ltd announced the settlement of an upside sharing amount of ₹127.68 Crore related to a prior divestment, following shareholder approval.
- Value
- ₹127.7 Cr
Anthem Biosciences Management Change
Anthem Biosciences appointed S.R. Batliboi & Associates LLP as Statutory Auditor and noted director changes, including a rotation and continuation of directorship.
Anthem Biosciences Annual General Meeting
Anthem Biosciences held its 20th AGM on July 22, 2026. Shareholders approved all business resolutions, including financial statements, dividend declaration, and statutory auditor appointments.
Anthem Biosciences Earnings Call Transcript: Key Takeaways
Revenue fell 25% YoY due to deferred deliveries, though management claims a record order book will drive second-half recovery. While EBITDA margins remain high at 39.6%, the quarter reflects high lumpiness in the CRDMO business.
Other other announcement announcements
All →Infonative Solutions Other Announcement
Infonative Solutions reported nil investor complaints for the quarter ended 30 September 2026, as required under Regulation 13(3). This is compliance with no financial or business impact.
Fusion Klassroom Edutech Other Announcement
Fusion Klassroom Edutech filed its Reg 32 statement of IPO proceeds utilisation for the quarter and half year ended 30 September 2026. No deviation or variation is reported.
Parth Electricals & Engineering Other Announcement
Parth Electricals filed its fifth Monitoring Agency Report for the quarter ended September 30, 2026. It confirms no deviation from the issue objects.
KHFM Hospitality & Facility Management Services Other Announcement
KHFM filed a non-applicability notice for the Corporate Governance Report for the quarter ended 30 September 2026, with a practising CS certificate. This is routine compliance paperwork with no business or financial event.
Motilal Oswal Financial Services Other Announcement
Motilal Oswal Financial Services certifies utilisation of proceeds from listed Commercial Papers issued in the quarter ended September 30, 2026, and adherence to listing conditions. This is a periodic regulatory compliance certificate.
Invigorated Business Consulting Other Announcement
Invigorated Business Consulting appointed GAV & Associates as statutory auditor from 1 April 2027 for 60 months. The routine appointment carries no financial impact.
- Execution
- 60 months from 1 April 2027